ProxyPatient
ProxyPatient grows tiny 3-D models—called organoids—directly from your own biopsied tissue sample. These living models mimic how your cancer behaves, allowing doctors to test different treatments in the lab first and predict which therapies are most likely to work for you.
– More accurate than traditional cell cultures
– Ability to test multiple therapies at once
– Prediction of both efficacy and potential side-effects
– Reduced trial-and-error in selecting treatment
A small biopsy is taken from your tumor or organ.
In our lab, we grow miniature 3D models of your condition called a “patient-derived organoid”
Candidate therapies are tested against your organoid.
Our AI evaluates how your cells respond.
Results are compiled to guide treatment discussions.
Services in development
ProxyPatient is currently limited to select cases that require highly specialized evaluation. The service is not yet FDA approved or covered by insurance, which unfortunately restricts access at this stage.
Even so, our goal is clear: to bring this technology from early adoption to broad availability, making personalized treatment guidance accessible to more patients in the future.
If you’re curious if we can help you or your patient, we’d be happy to discuss.
